Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
23,457
-17,734
-43% -$275K 0.11% 357
2026
Q1
$556K Buy
+41,191
New +$576K 0.16% 198

Other funds holding VTRS

AlphaGrep UK's VTRS Position: Q2 2026 in Review

AlphaGrep UK reduced its Viatris (VTRS) stake by 43% in Q2 2026, selling an estimated $275K and leaving 23,457 shares worth $372K. The position accounts for 0.11% of the portfolio, ranked #357.

AlphaGrep UK first reported a position in VTRS in Q1 2026 and has held it in 2 quarters since. The position peaked at $556K in Q1 2026. 969 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • AlphaGrep UK held 23,457 shares of Viatris worth $372K as of Q2 2026.
  • AlphaGrep UK sold 17,734 Viatris shares in Q2 2026, an estimated $275K.
  • Viatris made up 0.11% of AlphaGrep UK's portfolio in Q2 2026, its #357 holding.
  • AlphaGrep UK first reported a position in Viatris in Q1 2026 and has held it in 2 quarters since.
  • AlphaGrep UK's Viatris position peaked at $556K in Q1 2026.
  • 969 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.